iopromide has been researched along with Uterine Neoplasms in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maleux, G | 1 |
| Michielsen, K | 1 |
| Timmerman, D | 1 |
| Poppe, W | 1 |
| Heye, S | 1 |
| Vaninbroukx, J | 1 |
| Bosmans, H | 1 |
1 trial available for iopromide and Uterine Neoplasms
| Article | Year |
|---|---|
2D versus 3D roadmap for uterine artery catheterization: impact on several angiographic parameters.
Topics: Adult; Angiography; Catheterization; Contrast Media; Female; Humans; Imaging, Three-Dimensional; Ioh | 2014 |